Acute Erythroblastic Leukemia

Search Trials
Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 15, 2013
First Changed:
Dec 22, 2005
Disease(s):
Leukemia
Intervention(s):
cytarabinedaunorubicin hydrochlorideimatinib mesylate
Chemotherapy With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Aug 27, 2012
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
cytarabineetoposidegemtuzumab ozogamicinidarubicinmitoxantrone hydrochloride
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia
Status:
Completed
Last Changed:
Jun 11, 2010
First Changed:
Jul 29, 2004
Disease(s):
Leukemia
Intervention(s):
etoposidetopotecan hydrochloride
S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Mar 6, 2015
First Changed:
May 12, 2009
Disease(s):
Leukemia
Intervention(s):
DNA analysisDNA methylation analysisRNA analysisgene expression analysisreverse transcriptase-polymerase chain reactionlaboratory biomarker analysis
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia
Status:
Completed
Last Changed:
Oct 16, 2013
First Changed:
Nov 24, 2005
Disease(s):
Leukemia
Intervention(s):
filgrastimcladribinecytarabineimatinib mesylate

Connect. Empower. Inspire.